Overall, these studies seem to support the notion that vascular changes are associated with tau pathology, potentially at difference with amyloid pathology, as also demonstrated by autopsy data.218 Future studies systematically investigating the relationship between cerebrovascular disease and Alzheimer’s disease pathology219 are warranted to potentially guide the design of future clinical trials and/or interventions. This evidence concerns the gene MAPT and Alzheimer disease.